Sensus Healthcare (NASDAQ:SRTS) Share Price Crosses Below 50-Day Moving Average – Here’s Why

Shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.63 and traded as low as $4.57. Sensus Healthcare shares last traded at $4.77, with a volume of 130,239 shares traded.

Analyst Ratings Changes

A number of equities research analysts have commented on SRTS shares. Lake Street Capital decreased their price target on Sensus Healthcare from $18.00 to $13.00 and set a “buy” rating for the company in a research note on Tuesday, March 11th. HC Wainwright increased their price objective on shares of Sensus Healthcare from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Monday, February 10th.

Sensus Healthcare Trading Up 1.7 %

The stock has a 50-day simple moving average of $5.63 and a 200 day simple moving average of $6.54. The company has a market cap of $78.68 million, a price-to-earnings ratio of 11.93 and a beta of 1.28.

Sensus Healthcare (NASDAQ:SRTS) last released its earnings results on Wednesday, February 5th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. As a group, research analysts forecast that Sensus Healthcare, Inc. will post 0.32 EPS for the current fiscal year.

Institutional Trading of Sensus Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in SRTS. Squarepoint Ops LLC lifted its holdings in shares of Sensus Healthcare by 175.5% in the 4th quarter. Squarepoint Ops LLC now owns 85,677 shares of the company’s stock valued at $593,000 after buying an additional 54,576 shares during the period. Man Group plc raised its position in Sensus Healthcare by 34.0% during the fourth quarter. Man Group plc now owns 59,338 shares of the company’s stock valued at $411,000 after acquiring an additional 15,059 shares in the last quarter. OMERS ADMINISTRATION Corp acquired a new position in Sensus Healthcare in the fourth quarter valued at approximately $381,000. Millennium Management LLC boosted its position in Sensus Healthcare by 256.6% in the 4th quarter. Millennium Management LLC now owns 85,329 shares of the company’s stock worth $590,000 after purchasing an additional 61,403 shares in the last quarter. Finally, BNP Paribas Financial Markets purchased a new stake in Sensus Healthcare during the fourth quarter worth $47,000. Institutional investors and hedge funds own 25.30% of the company’s stock.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.